Buy Full Version
"Therapeutic Electrodes Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Therapeutic Electrodes Market by Product (Transcutaneous Electrical Nerve Stimulation (TENS) Electrodes, Pacemaker Electrodes, Electrosurgical Electrodes, and Defibrillator Electrodes), by Type (Disposables, and Reusables), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others) - Global Opportunity Analysis and Industry Forecast, 2019-2026

Medical Devices & Supplies	LI_183761	Pages: NA	Jan 2020 \| 1069 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Therapeutic electrodes are devices that can provide accurate clinical information with an introduction of medicines through the skin by ionization. Therapeutic electrodes are applied to the body to induce a therapeutic action to provide electric diagnosis of the case. Therapeutic electrodes are used in a wide range of medical indications such as nerve stimulation, cardiac rhythm management, glucose monitoring, and others.

The factors that drive the growth of the global therapeutic electrodes market are rise in public awareness about cardiovascular diseases (CVDs) through governments and non-profit organizations (NPOs) awareness programs & high incidence of hospital-acquired infections worldwide. For instance, as per CDC estimates, about 4% of the population or 1.7 million individuals in the U.S. are affected by hospital-acquired infections annually. However, risks associated with therapeutic electrodes such as allergic reactions and stringent government regulations form the restraints for the market growth. In addition, increased R&D by key players is anticipated to provide lucrative growth opportunities to the market.

The report segments the global therapeutic electrodes market based on product, type, and end user. Based on product, the market is divided into transcutaneous electrical nerve stimulation (TENS) electrodes, pacemaker electrodes, electrosurgical electrodes, and defibrillator electrodes. In terms of type, the market is categorized into disposables and reusables. Based on end user, the market is divided into hospitals, ambulatory surgical center, clinics, and others. Regionally, the market has been analyzed in North America, Europe, Asia-Pacific, and LAMEA.

Key players of the global therapeutic electrodes market are Medtronic plc, 3M Company, Ambu A/S, Adhex Technologies, Allied Medical Limited, Beurer GmbH, RS Medical, Rothacher Medical GmbH, Abbott Laboratories, and Bound Tree Medical.

Key Benefits

The study provides an in-depth analysis of the global therapeutic electrodes market and the current trends & future estimations to elucidate imminent investment pockets from 2016 to 2023.
The report presents quantitative analysis of the market to enable stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the market based on product type assists in understanding the trends in the industry.
Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

Therapeutic Electrodes Market Key Segments:

By Product

Transcutaneous Electrical Nerve Stimulation (TENS) Electrodes
Pacemaker Electrodes
Electrosurgical Electrodes
Defibrillator Electrodes

By Type

Disposables
Reusables

By End User

Hospitals
Ambulatory Surgical Center
Clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Venezuela
- Israel
- Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

CHAPTER 4 GLOBAL THERAPEUTIC ELECTRODES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ELECTROSURGICAL ELECTRODES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. PACEMAKER ELECTRODES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. DEFIBRILLATOR ELECTRODES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 GLOBAL THERAPEUTIC ELECTRODES MARKET, BY TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DISPOSABLES

5.2.1. Market size and forecast

5.3. REUSABLES

5.3.1. Market size and forecast

CHAPTER 6 GLOBAL THERAPEUTIC ELECTRODES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTER

6.3.1. Market size and forecast

6.4. CLINICS

6.3.1. Market size and forecast

6.5. OTHERS

6.3.1. Market size and forecast

CHAPTER 7 GLOBAL THERAPEUTIC ELECTRODES MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America Therapeutic Electrodes Market by Product
7.2.5. North America Therapeutic Electrodes Market by Type
7.2.6. North America Therapeutic Electrodes Market by End user

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe Therapeutic Electrodes Market by Product
7.3.5. Europe Therapeutic Electrodes Market by Type
7.3.6. Europe Therapeutic Electrodes Market by End user

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific Therapeutic Electrodes Market by Product
7.4.5. Asia-Pacific Therapeutic Electrodes Market by Type
7.4.6. Asia-Pacific Therapeutic Electrodes Market by End user

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Israel market size and forecast
7.5.3.3. Venezuela market size and forecast
7.5.3.4. Saudi Arabia market size and forecast
7.5.3.5. South Africa market size and forecast
7.5.3.6. Rest of LAMEA market size and forecast

7.5.4. LAMEA Therapeutic Electrodes Market by Product
7.5.5. LAMEA Therapeutic Electrodes Market by Type
7.5.6. LAMEA Therapeutic Electrodes Market by End user

CHAPTER 8 COMPANY PROFILES

8.1. 3M COMPANY

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. AMBU A/S

8.2.1. Operating business segments
8.2.3. Business performance
8.2.3. Key strategic moves and developments

8.3. ADHEX TECHNOLOGIES

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. ALLIED MEDICAL LIMITED

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. BEURER GMBH

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. MEDTRONIC PLC

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. RS MEDICAL

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. ROTHACHER MEDICAL GMBH

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.8. ABBOTT LABORATORIES

9.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. BOUND TREE MEDICAL

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com